Skip to main content
Equibles

SCHRODER INVESTMENT MANAGEMENT GROUP

Position in ARDX — Ardelyx, Inc.

CIK 1086619 London, X0
Back to ARDX Full portfolio

Position in ARDX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$5,922,313
+$3,407,903 QoQ
Shares Held
1,161,238
+176.6% QoQ
Ownership
0.466%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 250 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SCHRODER INVESTMENT MANAGEMENT GROUP holds $692,439,062 across 60 Biotechnology names. ARDX ranks #33 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TECH
BIO-TECHNE Corp
 1,410,943 $99,683,122
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 169,270 $84,081,485
3 EXEL
Exelixis, Inc.
 669,005 $36,400,560
4 INSM
INSMED Inc
 298,372 $31,812,422
5 ALNY
Alnylam Pharmaceuticals, Inc.
 95,194 $28,656,248
6 MDGL
Madrigal Pharmaceuticals, Inc.
 51,630 $27,722,728
7 VERA
Vera Therapeutics, Inc.
 510,787 $21,917,869
8 TVTX
Travere Therapeutics, Inc.
 379,611 $21,565,700

All Filings in ARDX

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,922,313 1,161,238
2026-03-31 $2,514,410 419,768
2025-12-31 $2,148,051 368,448